Clinical Trial Update: Study of DSP-0390 in Patients With Recurrent High-Grade Glioma [EARLY_Phase 1]

View source ↗

Summary

DSP-0390 is being studied in an early-phase Phase 1 trial for recurrent high-grade glioma, including glioblastoma, and the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• DSP-0390

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: High Grade Glioma, Glioblastoma Multiforme | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING